Bernstein Harold sold MAZE
June 1, 2026 · Form 4 insider transaction
Bernstein Harold sold 1,600 shares of Maze Therapeutics, Inc. at $26.36 per share, a transaction worth $42.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,600
Price
$26.36
Total value
$42.2K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.16 to $26.53 per share, inclusive.